This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Breathe BioMedical (BRTH) Stock Overview

A development-stage medical technology company, focuses on developing a breath test to detect early-stage breast cancer in women. More details

BRTH fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	1/6
Dividends	0/6

Risk Analysis

Has less than 1 year of cash runway

Shares are highly illiquid

Makes less than USD$1m in revenue (CA$0)

Does not have a meaningful market cap ($55M)

BRTH Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Breathe BioMedical Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Breathe BioMedical
Historical stock prices
Current Share Price	US$5.00
52 Week High	US$0
52 Week Low	US$0
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	BRTH	US Medical Equipment	US Market
7D	n/a	0.1%	3.4%
1Y	n/a	-8.5%	28.4%

Return vs Industry: Insufficient data to determine how BRTH performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how BRTH performed against the US Market.

Price Volatility

Is BRTH's price volatile compared to industry and market?
BRTH volatility
BRTH Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	7.9%
Market Average Movement	7.1%
10% most volatile stocks in US Market	16.0%
10% least volatile stocks in US Market	3.3%

Stable Share Price: BRTH has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine BRTH's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2005	26	William Dawes	breathebiomedical.com

Breathe BioMedical Inc., a development-stage medical technology company, focuses on developing a breath test to detect early-stage breast cancer in women. Its test consists of SohnoXB Breath Sampler, a tabletop device that is used to collect alveolar breath from patients; a breath collection kit to store the breath sample during transportation to its laboratory facilities; a spectrometer to process breath samples; and a machine learning algorithm to analyze the breath spectral data from the spectrometer. Breathe BioMedical Inc. was formerly known as Picomole Inc. and changed its name to Breathe BioMedical Inc. in November 2023.

Breathe BioMedical Inc. Fundamentals Summary

How do Breathe BioMedical's earnings and revenue compare to its market cap?
BRTH fundamental statistics
Market cap	US$54.57m
Earnings (TTM)	-US$7.83m
Revenue (TTM)	n/a

0.0x

P/S Ratio

-7.0x

P/E Ratio

Is BRTH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BRTH income statement (TTM)
Revenue	CA$0
Cost of Revenue	CA$0
Gross Profit	CA$0
Other Expenses	CA$10.54m
Earnings	-CA$10.54m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.97
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	1,548.4%

How did BRTH perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/08/27 04:14
End of Day Share Price	2024/08/27 00:00
Earnings	2024/03/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Breathe BioMedical Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.